BRIEF-Bayer starts phase III trial of VEGF Trap-Eye in Asia, Russia
FRANKFURT Feb 19 (Reuters) - Bayer AG : * Says initiated phase III trial of VEGF Trap-Eye for the treatment of diabetic
macular edema in Asia and Russia
- Exclusive: Secret contract tied NSA and security industry pioneer |
- U.S. aircraft hit by gunfire in South Sudan as conflict worsens
- With Fed out of the way, what's next on Wall Street?
- Four men arrested in deadly N.J. shopping mall carjacking
- Analysis: Lost Brazil order raises threat to Boeing fighter jets